Although many microRNAs (miRNAs) and their targets have been identified, the importance of miRNAs in vivo is still unclear. In this issue, Zhao et al. (2007) generate mice deficient in a cardiac-specific miRNA, miR-1-2, and reveal that this microRNA plays a crucial role in heart development and physiology.
For short periods of time, the human brain can consciously hold onto thoughts. This cognitive function, which is referred to as working memory, allows us to respond efficiently to the varying environmental demands of everyday life (Baddeley, 1986) . Consider, for example, a waiter who takes your order at a restaurant without using a notepad. To relay your order to the cook, he must maintain in working memory all the dishes you wanted plus any special requests. This information is short-lived-it may be erased once the food is brought to your table-but in the meantime it should be resistant to distractions, such as conversations with other people on the way to the kitchen. Although this is a complex cognitive function, a large body of experimental work has shown that neural circuits in the brain's prefrontal cortex mediate working memory.
In this issue of Cell, Wang et al. (2007) report in several mammalian models the results of an experimental tour de force aimed at understanding some of the key molecular processes that regulate neural circuits of the prefrontal cortex during tasks that require spatial working memory. They discovered that the mental representation of a spatial location held in working memory depends on the interaction between the postsynaptic α2A-adrenoceptors (α2A-ARs) and a class of ion channels called hyperpolarization-activated cyclic nucleotide channels (HCNs), which are gated by cAMP. This is a remarkable advance, not only because they tease out the functional interaction between these molecules and their effect on working memory, but also because the results provide a rational basis for the development of clinical therapies to treat mental disorders involving the prefrontal cortex. Funahashi et al. (1989) originally showed that, in monkeys performing a task involving spatial working memory, neurons in the prefrontal cortex respond selectively to memorized locations. In this now classic task, a small visual cue is briefly presented along a circle, and monkeys have to remember its position for few seconds during what is called the delay period; the position of the cue changes from trial to trial. Individual cells in the prefrontal cortex are selectively active during the delay period, such that some neurons fire action potentials at a high rate only when the position being remembered is at or near a specific preferred direction. This preferred direction varies from cell to cell. In this way, specific populations of neurons maintain a representation of the location of any stimulus presented in the visual field. It was later shown that sustaining this activity depends on strong connections within these networks (Compte et al., 2000) . In essence, neurons with similar spatial preferences tend to excite each other, whereas neurons with dissimilar spatial preferences tend to inhibit each other, such that only a few neurons remain strongly active during the delay period.
Neurons in the prefrontal cortex are modulated by inputs from the norepinephrine system, which projects to the prefrontal cortex from the brain stem. The influence of norepinephrine is mediated via postsynaptic α2A-ARs, and manipulation of these receptors can strongly affect work-
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Emilio Salinas 1 and Ranulfo Romo 2, * ing memory in monkeys and rodents. Both impairment (by α2A-AR blockade) and enhancement (by α2A-AR stimulation) of working memory have been reported (Arnsten et al., 1988) . Therefore, a natural question to ask is how do the α2A-ARs affect the persistent activity of these neurons during spatial working memory tasks? And, are there other molecules linking α2A-AR activation to the changes in activity that are triggered during the delay period?
In the current study, Arnsten and colleagues confront these challenging questions using electrophysiological, pharmacological and anatomical approaches (Wang et al. 2007 ). First, they trained monkeys to report the memorized location of a previously presented visual cue. While the monkeys performed the task, they injected α2A-AR agonists near the neurons that were being recorded to roughly mimic the release of norepinephrine from synaptic terminals. The idea was to directly test the effects of α2A-AR agonists and antagonists on neurons of the prefrontal cortex that are active during the delay period. They found that in most of the neurons tested, the α2A-AR agonist guanfacine significantly increased the level of sustained activity for the preferred stimulus direction but not for the nonpreferred directions. In contrast, application of yohimbine, an α2A-AR antagonist, in general suppressed only the activity of neurons responding to their preferred direction.
Also, coadministration of yohimbine reversed the enhancing effects of guanfacine. Computer simulations of circuits in the prefrontal cortex indicate that the robustness of the response (that is, how resistant the sustained activity is to distractors) increases as a function of the difference between responses to preferred and nonpreferred items (Compte et al., 2000) . Therefore, these elegant pharmacological studies show that by regulating the spatial tuning of these neurons, norepinephrine controls the strength of the representation of spatial location held in working memory.
Next, the authors investigated the biochemical events that follow the activation of α2A-ARs. Previous behavioral studies in rats have shown that elevated levels of cAMP impair spatial working memory and likewise inhibition of cAMP improves memory performance (Ramos et al., 2003 (Ramos et al., , 2006 . Wang et al. (2007) applied various drugs that either mimicked or blocked the effects of cAMP while monkeys performed the working memory task. Etazolate, which increases the endogenous level of cAMP, suppressed the activity of neurons at their preferred spatial locations during the delay period, whereas application of a cAMP inhibitor typically enhanced this activity. Again, this enhancing effect was reversed by subsequent administration of an analog of cAMP. Additionally, the α2A-AR agonist guanfacine enhanced delay-related firing via inhibition of cAMP. Taken together, these results suggested that the action of norepinephrine on neurons of the prefrontal cortex is mediated by cAMP.
Then, Wang et al. (2007) investigated what happens downstream of the cAMP signal. Previous studies had shown that cAMP increases the open state of HCN channels, which affect a neuron's membrane voltage and thus its capacity to produce action potentials (Poolos et al., 2002) . Following up on this clue, the authors administered an HCN channel blocker and found that, and found that, during the delay period, it significantly increased neuronal firing at the preferred location in most of the neurons tested. These effects were almost identical to those observed with the α2A-AR agonist guanfacine. Crucially, the suppressive effects of both yohimbine (which blocks α2A-ARs) and etazolate (which increases the levels of cAMP) were reversed by coapplication of the HCN channel blocker. These observations were consistent with a cascade of events triggered by norepinephrine release: activation of α2A-ARs, a decrease in levels of cAMP, the closure of HCN channels, a decrease in membrane conductance, and an increase in the effectiveness of synaptic connections. This cascade increases the robustness of representations of the spatial location that are held in working memory.
To more directly probe the role of HCN channels, the authors made intracellular recordings in slices of the ferret brain. In this preparation, short periods of high firing activity occur spontaneously in neural circuits of the prefrontal cortex (Shu et al., 2003) . Blocking the HCN channels under these conditions dramatically increased the duration and strength of the reverberating bouts of activity. Presumably, what happens is that some of the depolarizing current injected by synapses of these neural circuits escapes through the HCN channels, so when these are closed, the synaptic potentials in effect become stronger. As the authors suggest, in the monkey prefrontal cortex, the closure of HCN channels probably enhances local network interactions in a similar way.
Still, a direct effect of HCN channels on performance in a working memory task had yet to be demonstrated, so the authors shifted to a rat model. First, they found that HCN is predominantly found at the apical dendrites in the superficial layers of the prefrontal cortex, where synaptic inputs from neighboring neurons are located. Second, they carried out two additional experiments: (1) blockade of HCN channels, and (2) knockdown of HCN channel expression through RNA interference. Both manipulations clearly improved the performance of rats in a T-maze task in which the animals had to remember their previously chosen route for several seconds. Thus, the activity of HCN channels did have a sizeable impact on behavior.
Finally, to seal the case, Wang et al. (2007) formulated a highly specific prediction stemming from their hypotheses: if activation of α2A-ARs controls working memory through the gating of HCN channels, then these two molecules should be anatomically colocalized. Indeed, microanatomical analyses of the monkey prefrontal cortex revealed that both α2A-ARs and HCN channels are typically found in the head and neck of dendritic spines and interestingly, are nearly always located away from active synaptic zones. Further analysis confirmed that α2A-ARs and HCN channels are found together on spine membranes, often within tens of nanometers of each other.
Individually, each one of these results is subject to possible alternative interpretations, but collectively they make an extremely strong case for the biochemical cascade proposed by the authors. Furthermore, this cascade has immediate implications for the design of effective clinical therapies, because an abnormal capacity for working memory is thought to contribute to cognitive deficits, such as attention deficit hyperactivity disorder (ADHD) (Scahill et al., 2001 ).
It is not often that changes in behavior can be traced to specific molecular interactions in the brain, and it is even more rare to see a complex cognitive function, such as working memory, dissected in this way. Indeed, the work by Wang et al. (2007) is a remarkable feat that sets a high standard for future research in neuroscience.
Organogenesis is a complex biological process that requires precise spatial and temporal control of gene expression. Recently, miRNAs have emerged as central posttranscriptional repressors of gene expression that interact with the 3′ untranslated region (UTR) of specific target mRNAs (Kloosterman and Plasterk, 2006) . In this issue of Cell, Zhao et al. (2007) investigate the role of miRNAs during cardiac development in mice. Using elegant genetics, these authors uncover important roles for the miRNA, miR-1-2, during heart morphogenesis in the mouse embryo and for the regulation of cardiomyocyte proliferation and electrophysiology in the adult heart (Zhao et al., 2007) .
To understand the role of miRNAs in the developing heart, the authors engineered mice that lacked the microRNA processing enzyme Dicer in heart tissue alone. These embryos showed cardiac failure due to a variety of developmental defects, including pericardial edema and underdevelopment of the ventricular myocardium. These phenotypes are consistent with the defects during heart development observed in zebrafish embryos devoid of Dicer function (Giraldez et al, 2005) To further investigate the role of miRNAs in cardiac development, the authors focused on miR-1, a highly abundant class of miRNAs in the mammalian heart. Two members of the miR-1 class of RNAs-miR-1-1 and miR-1-2-are specifically expressed in cardiac tissue and skeletal muscle. miR-1-1 and miR-1-2 are encoded separately but appear to target the same mRNAs. To determine the particular role of miR-1-2, the authors using a targeted deletion strategy to eliminate the locus coding for miR-1-2 without affecting adjacent genes. Fifty percent of mice lacking miR-1-2 died during
